Overview

The PATCH Trial (Prevention And Treatment of COVID-19 With Hydroxychloroquine)

Status:
Terminated
Trial end date:
2020-11-13
Target enrollment:
Participant gender:
Summary
The PATCH trial (Prevention And Treatment of COVID-19 with Hydroxychloroquine) is funded investigator-initiated trial that includes 3 cohorts. Cohort 1: a double-blind placebo controlled trial of high dose HCQ as a treatment for home bound COVID-19 positive patients; Cohort 2: a randomized study testing different doses of HCQ in hospitalized patients; Cohort 3: a double blind placebo controlled trial of low dose HCQ as a preventative medicine in health care workers.
Phase:
Phase 2
Details
Lead Sponsor:
Ravi Amaravadi, MD
Treatments:
Hydroxychloroquine